GFAP is an efficient biomarker in CSF, plasma, and saliva, which is associated with amyloid pathology, cognitive impairment, and AD, and can be used to extract significant information about AD mechanisms and find opportunities to identify diagnosis, prognosis and therapy.
Riddhi Upadhyay, T. Srinivasan, R. Umapriya et al.· International review of neur...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.